Total planned funding: $130,141,040
Allocations
Countries/Regions
Ukraine | $130,141,040 |
Organizational Types
Unknown | $36,023,361 |
Private Contractor | $29,790,981 |
NGO | $24,397,014 |
Own Agency | $16,243,383 |
Multi-lateral Agency | $10,625,607 |
University | $5,577,000 |
Implementing Agency | $4,172,000 |
Other USG Agency | $3,061,694 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $57,944,559 |
Treatment | $24,203,765 |
Prevention | $15,237,203 |
Management and Operations | $11,698,330 |
Testing | $11,107,615 |
Care | $9,949,568 |
Budget Codes
OHSS: Health Systems Strengthening | $29,771,361 |
HVSI: Strategic Information | $17,015,187 |
HTXS: Treatment: Adult Treatment | $12,772,651 |
HVMS: Management and Operations | $11,698,330 |
HTXD: Treatment: ARV Drugs | $11,431,114 |
HLAB: Laboratory Infrastructure | $11,158,011 |
HVCT: Testing: HIV Testing and Counseling | $11,107,615 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,157,557 |
HVTB: Care: TB/HIV | $6,123,340 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,978,138 |
HKID: Care: Orphans and Vulnerable Children | $2,005,193 |
HBHC: Care: Adult Care and Support | $1,821,035 |
HMBL: Biomedical Prevention: Blood Safety | $1,333,557 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $224,594 |
Top Partner Programs
Not Available:
$36,023,361
Countries/Regions
Chemonics International:
$16,719,470
Countries/Regions
USG Aggregated Agencies:
$15,664,383
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions